Two diseases, one approach: multitarget drug discovery in Alzheimer's and neglected tropical diseases
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Two diseases, one approach: multitarget drug discovery in Alzheimer's and neglected tropical diseases
Authors
Keywords
-
Journal
MedChemComm
Volume 5, Issue 7, Pages 853-861
Publisher
Royal Society of Chemistry (RSC)
Online
2014-03-17
DOI
10.1039/c4md00069b
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Toward the Development of Dual-Targeted Glyceraldehyde-3-phosphate Dehydrogenase/Trypanothione Reductase Inhibitors againstTrypanosoma bruceiandTrypanosoma cruzi
- (2014) Federica Belluti et al. ChemMedChem
- Glycosomal Targets for Anti-Trypanosomatid Drug Discovery
- (2014) X. Barros-Alvarez et al. CURRENT MEDICINAL CHEMISTRY
- Drug–drug interactions between antiretrovirals and drugs used in the management of neglected tropical diseases
- (2013) Kay Seden et al. AIDS
- Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline
- (2013) Parminder Raina et al. ANNALS OF INTERNAL MEDICINE
- Quinones bearing non-steroidal anti-inflammatory fragments as multitarget ligands for Alzheimer’s disease
- (2013) Federica Prati et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The Bivalent Ligand Approach as a Tool for Improving the in vitro Anti-Alzheimer Multitarget Profile of Dimebon
- (2013) Michela Rosini et al. ChemMedChem
- Human Disease and Drug Pharmacology, Complex as Real Life
- (2013) E. Viayna et al. CURRENT MEDICINAL CHEMISTRY
- Polypharmacology in a Single Drug: Multitarget Drugs
- (2013) M. L. Bolognesi CURRENT MEDICINAL CHEMISTRY
- Target deconvolution techniques in modern phenotypic profiling
- (2013) Jiyoun Lee et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Modulation of Prion by Small Molecules: From Monovalent to Bivalent and Multivalent Ligands
- (2013) Matteo Staderini et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Shifting from the single to the multitarget paradigm in drug discovery
- (2013) José L. Medina-Franco et al. DRUG DISCOVERY TODAY
- Complex diseases require complex therapies
- (2013) Ravi Iyengar EMBO REPORTS
- Ask the Experts: Drug discovery for the treatment of leishmaniasis, African sleeping sickness and Chagas disease
- (2013) Future Medicinal Chemistry
- Drug Discovery for Neglected Diseases: Molecular Target-Based and Phenotypic Approaches
- (2013) Ian H. Gilbert JOURNAL OF MEDICINAL CHEMISTRY
- Polypharmacology – Foe or Friend?
- (2013) Jens-Uwe Peters JOURNAL OF MEDICINAL CHEMISTRY
- Kinetoplastida: new therapeutic strategies
- (2013) S.L. Croft Parasite
- Pharmacological Characterization of Memoquin, a Multi-Target Compound for the Treatment of Alzheimer's Disease
- (2013) Valeria Capurro et al. PLoS One
- Impossible or Merely Difficult? Two Grand Challenges from a Biologist’s Perspective
- (2013) Bryan L. Roth ACS Medicinal Chemistry Letters
- Naphthoquinone Derivatives Exert Their Antitrypanosomal Activity via a Multi-Target Mechanism
- (2013) Simone Pieretti et al. PLoS Neglected Tropical Diseases
- Fire in the ashes: Can failed Alzheimer’s disease drugs succeed with second chances?
- (2012) Robert E. Becker et al. Alzheimers & Dementia
- Structural Determinants of the Multifunctional Profile of Dual Binding Site Acetylcholinesterase Inhibitors as Anti-Alzheimer Agents
- (2012) Carles Galdeano et al. CURRENT PHARMACEUTICAL DESIGN
- Network pharmacology for cancer drug discovery: are we there yet?
- (2012) Asfar S Azmi Future Medicinal Chemistry
- STRING v9.1: protein-protein interaction networks, with increased coverage and integration
- (2012) Andrea Franceschini et al. NUCLEIC ACIDS RESEARCH
- Multi-Target Drugs: The Trend of Drug Research and Development
- (2012) Jin-Jian Lu et al. PLoS One
- Polypharmacology: drug discovery for the future
- (2012) A Srinivas Reddy et al. Expert Review of Clinical Pharmacology
- Robustness of metabolic networks: A review of existing definitions
- (2011) Abdelhalim Larhlimi et al. BIOSYSTEMS
- Insight into Amyloid Structure Using Chemical Probes
- (2011) Ashley A. Reinke et al. Chemical Biology & Drug Design
- Multitarget-Directed Ligands: Innovative Chemical Probes and Therapeutic Tools Against Alzheimer's Disease
- (2011) Maria Laura Bolognesi et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Multi-Target-Directed Ligands as Innovative Tools to Combat Trypanosomatid Diseases
- (2011) Maria Laura Bolognesi CURRENT TOPICS IN MEDICINAL CHEMISTRY
- The role of fragment-based and computational methods in polypharmacology
- (2011) Giovanni Bottegoni et al. DRUG DISCOVERY TODAY
- Exploiting the lipoic acid structure in the search for novel multitarget ligands against Alzheimer’s disease
- (2011) Michela Rosini et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis of Monomeric Derivatives To Probe Memoquin’s Bivalent Interactions
- (2011) Maria Laura Bolognesi et al. JOURNAL OF MEDICINAL CHEMISTRY
- The worldwide societal costs of dementia: Estimates for 2009
- (2010) Anders Wimo et al. Alzheimers & Dementia
- In vitro antiamyloidogenic properties of 1,4-naphthoquinones
- (2010) Paloma Bermejo-Bescós et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Synthesis and evaluation of a library of 2,5-bisdiamino-benzoquinone derivatives as probes to modulate protein–protein interactions in prions
- (2010) Hoang Ngoc Ai Tran et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Multitargeted drugs discovery: Balancing anti-amyloid and anticholinesterase capacity in a single chemical entity
- (2010) Maria Laura Bolognesi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Strategies for the Inhibition of Protein Aggregation in Human Diseases
- (2010) Manuela Bartolini et al. CHEMBIOCHEM
- Bis(7)-tacrine Derivatives as Multitarget-Directed Ligands: Focus on Anticholinesterase and Antiamyloid Activities
- (2010) Maria Laura Bolognesi et al. ChemMedChem
- From Anti-allergic to Anti-Alzheimer ’ s: Molecular Pharmacology of Dimebon™
- (2010) I. Okun et al. Current Alzheimer Research
- Natural and Synthetic Naphthoquinones Active Against Trypanosoma Cruzi: An Initial Step Towards New Drugs for Chagas Disease
- (2010) Cristian O. Salas et al. CURRENT MEDICINAL CHEMISTRY
- Vaccines to combat the neglected tropical diseases
- (2010) Jeffrey M. Bethony et al. IMMUNOLOGICAL REVIEWS
- Parallel Synthesis, Evaluation, and Preliminary Structure−Activity Relationship of 2,5-Diamino-1,4-benzoquinones as a Novel Class of Bivalent Anti-Prion Compound
- (2010) Salvatore Bongarzone et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cognition-Enhancing Properties of Dimebon in a Rat Novel Object Recognition Task Are Unlikely to Be Associated with Acetylcholinesterase Inhibition or N-Methyl-D-aspartate Receptor Antagonism
- (2010) M. Giorgetti et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- In-Silico Approaches to Multi-target Drug Discovery
- (2010) Xiao Hua Ma et al. PHARMACEUTICAL RESEARCH
- Complete Phenotypic Recovery of an Alzheimer's Disease Model by a Quinone-Tryptophan Hybrid Aggregation Inhibitor
- (2010) Roni Scherzer-Attali et al. PLoS One
- Unveiling the role of network and systems biology in drug discovery
- (2010) Albert Pujol et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Mitochondrial production of reactive oxygen species: Role of Complex I and quinone analogues
- (2009) Romana Fato et al. BIOFACTORS
- Structure–activity relationships of memoquin: Influence of the chain chirality in the multi-target mechanism of action
- (2009) Maria Laura Bolognesi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Multivalent & Multifunctional Ligands to β-Amyloid
- (2009) YoungSoo Kim et al. CURRENT PHARMACEUTICAL DESIGN
- Designing Multiple Ligands – Medicinal Chemistry Strategies and Challenges
- (2009) Richard Morphy et al. CURRENT PHARMACEUTICAL DESIGN
- Natural products and drug discovery. Can thousands of years of ancient medical knowledge lead us to new and powerful drug combinations in the fight against cancer and dementia?
- (2009) Hong-Fang Ji et al. EMBO REPORTS
- Complementary medicinal chemistry-driven strategies toward new antitrypanosomal and antileishmanial lead drug candidates
- (2009) Andrea Cavalli et al. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
- The effects on Trypanosoma cruzi of novel synthetic naphthoquinones are mediated by mitochondrial dysfunction
- (2009) Rubem F.S. Menna-Barreto et al. FREE RADICAL BIOLOGY AND MEDICINE
- Treatment of visceral leishmaniasis with intravenous pentamidine and oral fluconazole in an HIV-positive patient with chronic renal failure — a case report and brief review of the literature
- (2009) Jan Rybniker et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Neglected Tropical Diseases: Multi-Target-Directed Ligands in the Search for Novel Lead Candidates againstTrypanosomaandLeishmania
- (2009) Andrea Cavalli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Toward a Rational Design of Multitarget-Directed Antioxidants: Merging Memoquin and Lipoic Acid Molecular Frameworks
- (2009) Maria Laura Bolognesi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Selectively Nonselective Kinase Inhibition: Striking the Right Balance
- (2009) Richard Morphy JOURNAL OF MEDICINAL CHEMISTRY
- The Trypanocidal Activity of Naphthoquinones: A Review
- (2009) Antônio Ventura Pinto et al. MOLECULES
- Deciphering complex mechanisms in neurodegenerative diseases: the advent of systems biology
- (2009) Farshid Noorbakhsh et al. TRENDS IN NEUROSCIENCES
- Design and Applications of Bifunctional Small Molecules: Why Two Heads Are Better Than One
- (2008) Timothy W. Corson et al. ACS Chemical Biology
- Synthesis of a small library of 2-phenoxy-1,4-naphthoquinone and 2-phenoxy-1,4-anthraquinone derivatives bearing anti-trypanosomal and anti-leishmanial activity
- (2008) Maria Laura Bolognesi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Multi-target-Directed Ligands To Combat Neurodegenerative Diseases
- (2008) Andrea Cavalli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dimebon in Alzheimer's disease: old drug for new indication
- (2008) Alistair Burns et al. LANCET
- Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study
- (2008) Rachelle S Doody et al. LANCET
- From Dual Binding Site Acetylcholinesterase Inhibitors to Multi-Target-Directed Ligands (MTDLs): A Step Forward in the Treatment of Alzheimers Disease
- (2008) Maria Bolognesi et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Network pharmacology: the next paradigm in drug discovery
- (2008) Andrew L Hopkins Nature Chemical Biology
- Memoquin: A multi-target-directed ligand as an innovative therapeutic opportunity for Alzheimer’s disease
- (2008) Maria Laura Bolognesi et al. Neurotherapeutics
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started